Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1935233

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1935233

Cell Culture Media for Vaccine Market, By Media Type, By Application, By Geography

PUBLISHED:
PAGES: 151 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Cell Culture Media For Vaccine Market is estimated to be valued at USD 2,217.6 Mn in 2026 and is expected to reach USD 3,727.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.7% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 2,217.6 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 7.70% 2033 Value Projection: USD 3,727.4 Mn

Cell culture media consists an appropriate source of energy and compounds, which supports growth of cells and regulate the cell cycle. A typical culture medium is composed of vitamins, inorganic salts, complement of amino acids, glucose, and serum which acts as source of growth factors, hormones, and attachment factors. Furthermore, the medium also helps to maintain pH and osmolality.

Market Dynamics

Increasing prevalence of infectious diseases is a major factor driving the global cell culture media for vaccine market growth. According to the Centers for Disease Control and Prevention (CDC), in August 2017, around 104 laboratory-confirmed influenza-associated pediatric deaths were reported, where 66 cases were associated with influenza A viruses and 38 cases were associated with influenza B viruses in the U.S. Moreover, the government initiatives for increasing awareness among the populace regarding prevention of diseases facilitated by vaccines is expected to boost the market growth. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2015, flu vaccinations prevented around 1.9 million flu illnesses, 966,000 flu-associated medical visits, and around 67,000 flu-associated hospitalizations, representing 6.5% lowering of disease burden in the U.S.

However, high risk of contamination may hinder the market growth. According to the article published in ResearchGate, 2014, fetal bovine serum (FBS) is known to contain factors such as endotoxins, mycoplasma, viral contaminants, and prions that can lead to bovine spongiform encephalopathy (BSE).

Key features of the study

  • This report provides in-depth analysis of the global cell culture media for vaccine market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 - 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights into market drivers, restraints, opportunities, impact analysis, Porter's analysis, PEST analysis, regulatory scenario, key developments, raw material analysis, and supply chain analysis
  • It profiles key players in the global cell culture media for vaccine market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include HiMedia Laboratories, Thermo Fisher Scientific Inc., Merck KGaA, General Electric Company, Sartorius AG, Proliant, Inc., Bovogen Biologicals Pty. Ltd., Rocky Mountain Biologicals, Valley Biomedical, Moregate BioTech, Atlanta Biologicals, Creative-Biolabs, Life Technologies (India) Pvt Ltd., Axil Scientific Pte Ltd., Indian Immunologicals Limited, Serum Institute of India Pvt. Ltd., Sisco Research Laboratories Pvt. Ltd., and Valneva SE
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global cell culture media for vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell culture media for vaccine market

Market Segmentation

  • By Media Type
    • Bovine Derived
    • Fetal bovine serum (FBS)
    • Newborn Calf Serum (NBCS)
    • Adult Bovine Serum (ABS)
    • Bovine Serum Albumin (BSA)
    • Bovine Calf Serum (BCS)
    • Porcine Derived
    • Animal free/Serum Free Cell Culture
  • By Application
    • Human Vaccines
    • Animal Vaccines
  • By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East & Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa
  • Key Players
    • HiMedia Laboratories
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • General Electric Company
    • Sartorius AG
    • Proliant, Inc.
    • Bovogen Biologicals Pty. Ltd.
    • Rocky Mountain Biologicals
    • Valley Biomedical
    • Moregate BioTech
    • Atlanta Biologicals
    • Creative-Biolabs
    • Life Technologies (India) Pvt Ltd.
    • Axil Scientific Pte Ltd.
    • Indian Immunologicals Limited
    • Serum Institute of India Pvt. Ltd.
    • Sisco Research Laboratories Pvt. Ltd.
    • Valneva SE
Product Code: CMI2608

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Media Type
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Porter's analysis
  • PEST analysis
  • Regulatory Scenario
  • Key Developments
  • Raw material analysis
  • Supply chain analysis

4. Global Cell Culture Media for Vaccine Market, By Media Type, 2026 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Bovine Derived
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Fetal bovine serum (FBS)
  • Newborn Calf Serum (NBCS)
  • Adult Bovine Serum (ABS)
  • Bovine Serum Albumin (BSA)
  • Bovine Calf Serum (BCS)
  • Porcine Derived
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Animal free/Serum Free Cell Culture
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

5. Global Cell Culture Media for Vaccine Market, By Application, 2026 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Human Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Animal Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

6. Global Cell Culture Media for Vaccine Market, By Region, 2026 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2026-2033
  • North America
    • Market Size and Forecast, By Media Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Market Size and Forecast, By Media Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Media Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Media Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Media Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Media Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
      • South Africa
      • Central Africa
      • North Africa

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • HiMedia Laboratories
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Thermo Fisher Scientific Inc.
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Merck KGaA
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • General Electric Company
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Sartorius AG
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Proliant, Inc.
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Bovogen Biologicals Pty. Ltd.
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Rocky Mountain Biologicals
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Valley Biomedical
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Moregate BioTech
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Atlanta Biologicals
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Creative-Biolabs
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Life Technologies (India) Pvt Ltd.
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Axil Scientific Pte Ltd.
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Indian Immunologicals Limited
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Serum Institute of India Pvt. Ltd.
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Valneva SE
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
      • Analyst Views

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!